CA2929126A1 - Vesicules de membrane externe et utilisation associees - Google Patents
Vesicules de membrane externe et utilisation associees Download PDFInfo
- Publication number
- CA2929126A1 CA2929126A1 CA2929126A CA2929126A CA2929126A1 CA 2929126 A1 CA2929126 A1 CA 2929126A1 CA 2929126 A CA2929126 A CA 2929126A CA 2929126 A CA2929126 A CA 2929126A CA 2929126 A1 CA2929126 A1 CA 2929126A1
- Authority
- CA
- Canada
- Prior art keywords
- francisella
- noatunensis
- fish
- spp
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0233—Rickettsiales, e.g. Anaplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361903684P | 2013-11-13 | 2013-11-13 | |
US61/903,684 | 2013-11-13 | ||
PCT/IB2014/003033 WO2015071769A2 (fr) | 2013-11-13 | 2014-11-13 | Vésicules de membrane externe et utilisation associées |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2929126A1 true CA2929126A1 (fr) | 2015-05-21 |
CA2929126C CA2929126C (fr) | 2020-01-07 |
Family
ID=52462343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2929126A Expired - Fee Related CA2929126C (fr) | 2013-11-13 | 2014-11-13 | Vesicules de membrane externe et utilisation associees |
Country Status (5)
Country | Link |
---|---|
US (2) | US9993541B2 (fr) |
EP (1) | EP3068426B1 (fr) |
CA (1) | CA2929126C (fr) |
CL (1) | CL2016001114A1 (fr) |
WO (1) | WO2015071769A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017137834A1 (fr) * | 2016-02-08 | 2017-08-17 | University Of Oslo | Milieux de culture bactérienne |
NO20200827A1 (en) * | 2017-12-26 | 2020-07-14 | Univ Chile | Vaccine formulation for fish based on lipid nanovesicles,particularly a proteoliposome or cochleate, with activity against the salmonid rickettsial syndrome (srs) |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
CZ282235B6 (cs) | 1992-06-25 | 1997-06-11 | Smithkline Beecham Biologicals (S.A.) | Očkovací prostředek, jeho použití k výrobě vakcíny, způsob léčby patogenních infekcí tímto prostředkem a způsob jeho výroby |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
ATE328890T1 (de) | 1994-07-15 | 2006-06-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
CA2182637A1 (fr) | 1995-08-04 | 1997-02-05 | Jagath L. Kadurugamuwa | Vaccins et compositions pharmaceutiques utilisant les vesicules de membranes de microorganismes; methodes de preparation |
ZA975326B (en) | 1996-06-18 | 1998-01-14 | Alza Corp | Device and method for enhancing transdermal flux of agents being delivered or sampled. |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
CA2271167C (fr) | 1996-12-20 | 2007-01-09 | Alza Corporation | Dispositif et procede permettant d'ameliorer le flux d'agent transdermique |
US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
DE69838992T2 (de) | 1997-09-05 | 2008-12-24 | Glaxosmithkline Biologicals S.A., Rixensart | Öl-in-Wasser Emulsionen mit Saponinen |
CN1285753A (zh) | 1997-12-02 | 2001-02-28 | 鲍德杰克特疫苗公司 | 透皮给药微粒疫苗组合物 |
WO2003030934A2 (fr) | 2001-10-06 | 2003-04-17 | Merial Limited | Formulations cpg et procedes y relatifs |
US7754223B2 (en) * | 2003-10-07 | 2010-07-13 | Eurogentec Sa | Piscirickettsia salmonis antigens and use thereof |
WO2007047501A2 (fr) * | 2005-10-14 | 2007-04-26 | George Mason University | Vésicules de membrane externe : nouveau vaccin pour agents biomenaces gram négatifs |
CL2007001893A1 (es) | 2006-06-29 | 2008-01-04 | Pharmaq As | Proceso para cultivar una bacteria del genero piscirickettsia en un medio cultivo libre de celulas huesped; proceso para obtener dichas bacterias; vacuna que comprende dichas bacterias; y alimento que comprende dicha vacuna para la prevencion de infecciones en peces con bacterias del genero piscirickettsia. |
US8147820B2 (en) | 2009-09-14 | 2012-04-03 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Attenuated vaccine against fish pathogen Francisella sp |
US20140004178A1 (en) | 2011-01-12 | 2014-01-02 | The Administrators Of The Tulane Educational Fund | Omv vaccine against burkholderia infections |
CA2930641A1 (fr) | 2013-11-13 | 2015-05-28 | Norges Miljo- Og Biovitenskapelige Universitet (Nmbu) | Vaccin pour poissons |
US10022433B2 (en) | 2013-11-13 | 2018-07-17 | Previwo As | Fish vaccine |
-
2014
- 2014-11-13 US US15/034,330 patent/US9993541B2/en not_active Expired - Fee Related
- 2014-11-13 EP EP14835493.9A patent/EP3068426B1/fr active Active
- 2014-11-13 WO PCT/IB2014/003033 patent/WO2015071769A2/fr active Application Filing
- 2014-11-13 CA CA2929126A patent/CA2929126C/fr not_active Expired - Fee Related
-
2016
- 2016-05-10 CL CL2016001114A patent/CL2016001114A1/es unknown
-
2018
- 2018-05-23 US US15/986,955 patent/US10314902B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2929126C (fr) | 2020-01-07 |
US9993541B2 (en) | 2018-06-12 |
WO2015071769A3 (fr) | 2015-11-12 |
US10314902B2 (en) | 2019-06-11 |
EP3068426A2 (fr) | 2016-09-21 |
US20160279222A1 (en) | 2016-09-29 |
WO2015071769A2 (fr) | 2015-05-21 |
CL2016001114A1 (es) | 2017-03-24 |
EP3068426B1 (fr) | 2020-02-12 |
US20180271967A1 (en) | 2018-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8669355B2 (en) | Vaccine | |
Mo et al. | Potential of naturally attenuated Streptococcus agalactiae as a live vaccine in Nile tilapia (Oreochromis niloticus) | |
US7707970B2 (en) | Vaccine against salmonid rickettsial septicaemia based on Arthrobacter cells | |
US10314902B2 (en) | Outer membrane vesicles and uses thereof | |
AU2008320818A1 (en) | Fish vaccine | |
JP2012510497A (ja) | ワクチンの生産方法 | |
Gestal et al. | Immunomodulation as a novel strategy for prevention and treatment of Bordetella spp. infections | |
Austin | Developments in vaccination against fish bacterial disease | |
WO2011079627A1 (fr) | Adjuvant à composants multiples d'un vaccin par immersion pour poissons, son application et sa méthode d'utilisation | |
JP2011506577A (ja) | 魚類ワクチン | |
US20200345825A1 (en) | Formulation of fish vaccine based on lipidic nanovesicles, in particular, a proteoliposome or cochleate, with activity against the salmonid rickettsial syndrome (srs) | |
KR101640716B1 (ko) | 면역보조제를 첨가한 스쿠티카충 백신 조성물 | |
US12005110B2 (en) | Honeybee commensal Snodgrassella alvi vaccine against pathogenic Neisseriaceae | |
Rajalakshmi et al. | Effect of using bivalent vaccines (Whole cell and Outer membrane protein) against the infections of Edwardsiella tarda and Pseudomonas fluorescens in Cirrhinus mrigala | |
CA2988165C (fr) | Compositions d'exotoxine/thermolysine et methodes et utilisations pour le traitement ou la prevention de la fourbure | |
WO2024003035A1 (fr) | Vaccins contre la piscirickettsiose (septicémie rickettsienne des salmonidés) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20160428 |
|
MKLA | Lapsed |
Effective date: 20211115 |